[Correspondence] Neo-adjuvant chemotherapy alone or with regional hyperthermia for soft-tissue sarcoma – Authors' reply

Sergey Roussakow comments on four issues of our trial:1 bias caused by imbalanced post-induction chemotherapy application between study groups, subgroup-based analysis of the study endpoints, unreliable evaluation of tumour response, and an overall outcome worse than expected.

http://ift.tt/2znEGPg